Company Filing History:
6 out of 142 
1 out of 832,912 Years Active: 1997-2003
Title: Nancy Wedel: Innovator in Therapeutic Protein Applications
Introduction
Nancy Wedel is a prominent inventor based in Oakland, CA (US). She has made significant contributions to the field of therapeutic protein applications, holding a total of 7 patents. Her work focuses on innovative methods for treating humans exposed to bacterial endotoxin, showcasing her dedication to advancing medical science.
Latest Patents
Among her latest patents, Nancy has developed methods for the human therapeutic uses of bactericidal/permeability-increasing (BPI) protein products. These methods aim to treat individuals exposed to bacterial endotoxin in circulation. The treatments have demonstrated serologically and hematologically verifiable alleviation of endotoxin-mediated increases in circulating cytokines, fibrinolysis, and coagulation factors. Additionally, changes in lymphocyte counts have been observed upon treatment. The research also highlights the alleviation of endotoxin-mediated decreases in systemic vascular resistance index (SVRI) and concomitant increases in cardiac index (CI).
Career Highlights
Nancy has worked with notable organizations, including Xoma Corporation, where she has contributed her expertise in therapeutic protein research. Her innovative approaches have positioned her as a key figure in the development of medical treatments that address critical health challenges.
Collaborations
Throughout her career, Nancy has collaborated with esteemed colleagues such as Patrick J. Scannon and Nadav Friedmann. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Nancy Wedel's contributions to the field of therapeutic protein applications exemplify her commitment to innovation and improving human health. Her patents and collaborations reflect her significant role in advancing medical treatments.